OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The gut microbiome in sickle cell disease: Characterization and potential implications
Hassan Brim, James G. Taylor, Muneer Abbas, et al.
PLoS ONE (2021) Vol. 16, Iss. 8, pp. e0255956-e0255956
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Sickle Cell Disease Update: New Treatments and Challenging Nutritional Interventions
Victoria Bell, Theodoros Varzakas, Θεοδώρα Ψαλτοπούλου, et al.
Nutrients (2024) Vol. 16, Iss. 2, pp. 258-258
Open Access | Times Cited: 14

In vivo evaluation of the effect of sickle cell hemoglobin S, C and therapeutic transfusion on erythrocyte metabolism and cardiorenal dysfunction
Angelo D’Alessandro, Mehdi Nouraie, Yingze Zhang, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 7, pp. 1017-1028
Open Access | Times Cited: 22

Intestinal barrier functions in hematologic and oncologic diseases
Elio Haroun, Prashanth Ashok Kumar, Ludovic Saba, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12

Implementation of a Low-risk Algorithm for Outpatient Management of Febrile Pediatric Patients With Sickle Cell Disease
Jason Erno, Laurence Noisette, Shayla Bergmann, et al.
Journal of Pediatric Hematology/Oncology (2025) Vol. 47, Iss. 2, pp. 80-85
Open Access

L-glutamine for sickle cell disease: more than reducing redox
Firas Jafri, Gyuhee Seong, Tim Jang, et al.
Annals of Hematology (2022) Vol. 101, Iss. 8, pp. 1645-1654
Closed Access | Times Cited: 16

Microbial gut evaluation in an angolan paediatric population with sickle cell disease
Mariana Delgadinho, Catarina Ginete, Brígida Santos, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 21, pp. 5360-5368
Open Access | Times Cited: 15

Intestinal barrier dysfunction in murine sickle cell disease is associated with small intestine neutrophilic inflammation, oxidative stress, and dysbiosis
Caitlin Lewis, Hassan Sellak, Mariem A. Sawan, et al.
FASEB BioAdvances (2023) Vol. 5, Iss. 5, pp. 199-210
Open Access | Times Cited: 7

Dietary iron restriction protects against vaso-occlusion and organ damage in murine sickle cell disease
Huihui Li, Jacob S Kazmi, Sung Kyun Lee, et al.
Blood (2022) Vol. 141, Iss. 2, pp. 194-199
Open Access | Times Cited: 12

Gut Microbiota: Potential Therapeutic Target for Sickle Cell Disease Pain and Complications
Tarimoboere Agbalalah, Doofan Bur, Ezinne Janefrances Nwonu, et al.
Anemia (2024) Vol. 2024, pp. 1-8
Open Access | Times Cited: 2

Recent advances in “sickle and niche” research - Tribute to Dr. Paul S Frenette -
Lidiane S. Torres, Noboru Asada, Mitchell J. Weiss, et al.
Stem Cell Reports (2022) Vol. 17, Iss. 7, pp. 1509-1535
Open Access | Times Cited: 11

Bone loss is ameliorated by fecal microbiota transplantation through SCFA/GPR41/ IGF1 pathway in sickle cell disease mice
Liping Xiao, Yanjiao Zhou, Suresh Bokoliya, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11

Protective Effect of Ganoderma lucidum Spore Powder on Acute Liver Injury in Mice and its Regulation of Gut Microbiota
Yue Leng, Fang Wang, Changbao Chen, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 2, pp. 23-23
Open Access | Times Cited: 5

Effects of GBT1118, a voxelotor analog, on intestinal pathophysiology in sickle cell disease
Elio Haroun, Dibyendu Dutta, Seah H. Lim
British Journal of Haematology (2023) Vol. 202, Iss. 1, pp. 184-194
Closed Access | Times Cited: 5

The relationship between nutrition, gut dysbiosis, and pediatric sickle cell pain outcomes: A pilot study
Chinenye R. Dike, Corrine Hanson, H. Dele Davies, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. 7
Open Access | Times Cited: 5

Gut microbiota and metabolites drive chronic sickle cell disease pain
Katelyn E. Sadler, Samantha N. Atkinson, Vanessa Ehlers, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5

Differential expression of adhesion molecules in sickle cell anemia and gut microbiome effect
Mariana Delgadinho, Luísa Veiga, Catarina Ginete, et al.
Annals of Hematology (2023) Vol. 103, Iss. 2, pp. 409-419
Open Access | Times Cited: 5

Pathophysiological characterization of the Townes mouse model for sickle cell disease
Juliana Alvarez‐Argote, Theresa A. Dlugi, Teresa Sundararajan, et al.
Translational research (2022) Vol. 254, pp. 77-91
Closed Access | Times Cited: 8

Unmet Need: Mechanistic and Translational Studies of Sickle Cell Disease Pain as a Whole-Person Health Challenge
Inna Belfer, Wen Chen, Wendy Weber, et al.
Journal of Pain (2024) Vol. 25, Iss. 10, pp. 104603-104603
Closed Access | Times Cited: 1

Causal relationship between gut microbes and cardiovascular protein expression
Wenchuan Zhang, Shuwan Zhang, Feng Zhao, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 6

Neutrophils as drivers of vascular injury in sickle cell disease
Lidiane S. Torres, Andrés Hidalgo
Immunological Reviews (2022) Vol. 314, Iss. 1, pp. 302-312
Open Access | Times Cited: 5

Severe anemia in preterm infants associated with increased bacterial virulence potential and metabolic disequilibrium
Justin Gibbons, L M Worthington, En-Chi Chiu, et al.
Pediatric Research (2024)
Closed Access

In vivoevaluation of the effect of sickle cell hemoglobin S, C and therapeutic transfusion on erythrocyte metabolism and cardiorenal dysfunction
Angelo D’Alessandro, Mehdi Nouraie, Yingze Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

Hypercoagulability in Sickle Cell Disease: A Thrombo-Inflammatory Mechanism
Hassan A. Hamali
Hemoglobin (2023) Vol. 47, Iss. 6, pp. 205-214
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top